| C07005 |
Flunisolide; Flunisolide anhydrous |
(P) unclassified |
| C07370 |
Prednisone; 1,2-Dehydrocortisone; 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione |
(P) unclassified |
| D00088 |
Hydrocortisone (JP18/USP/INN); HC; Acticort (TN); Anusol HC (TN); Colocort (TN); Cortef (TN); Hytone (TN); Plenadren (TN) |
(P) unclassified |
| D00107 |
Tacrolimus (USP/INN); Tacrolimus hydrate (JP18); Prograf (TN); Protopic (TN) |
(P) Enzyme: CYP3A4 |
| D00126 |
Ibuprofen (JP18/USP/INN); Advil (TN); Motrin (TN) |
(P) CYP inhibition: CYP2C9 |
| D00142 |
Methotrexate (JP18/USP/INN); Otrexup (TN); Xatmep (TN) |
(P) unclassified |
| D00165 |
Hydrocortisone acetate (JP18/USP); Cortifoam (TN); U-cort (TN) |
(P) unclassified |
| D00184 |
Cyclosporine (USP); Ciclosporin (JP18); Gengraf (TN); Neoral (TN); Restasis (TN); Sandimmune (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00211 |
Rifampin (USP); Rifampicin (JP18/INN); Rifadin (TN); Rimactane (TN) |
(P) CYP induction: CYP3A4 |
| D00237 |
Auranofin (JP18/USAN/INN); Ridaura (TN) |
(P) unclassified |
| D00238 |
Azathioprine (JP18/USP/INN); Azasan (TN); Imuran (TN); Jayempi (TN) |
(P) unclassified |
| D00244 |
Betamethasone (JP18/USP/INN); Celestone (TN); Rinderon (TN) |
(P) unclassified |
| D00246 |
Budesonide (JP18/USP/INN); Entocort EC (TN); Pulmicort (TN); Rhinocort (TN); Uceris (TN) |
(P) Enzyme: CYP3A4 |
| D00251 |
Captopril (JP18/USP/INN); Apopril (TN); Capoten (TN) |
(P) unclassified |
| D00252 |
Carbamazepine (JP18/USP/INN); Equetro (TN); Tegretol (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00292 |
Dexamethasone (JP18/USP/INN); Decadron (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00293 |
Diazepam (JP18/USP/INN); Diastat (TN); Valium (TN) |
(P) Enzyme: CYP3A4 |
| D00324 |
Flunisolide (JAN/USP); Aerospan (TN); Nasalide (TN) |
(P) Enzyme: CYP3A4 |
| D00325 |
Fluocinonide (JP18/USP/INN); Lidex (TN); Vanos (TN) |
(P) unclassified |
| D00328 |
Flurandrenolide (USP); Fludroxycortide (JAN/INN); Cordran (TN) |
(P) unclassified |
| D00330 |
Flurbiprofen (JP18/USP/INN); Ansaid (TN) |
(P) CYP inhibition: CYP2C9 |
| D00333 |
Ganciclovir (JAN/USP/INN); Cytovene (TN); Vitrasert (TN); Zirgan (TN) |
(P) unclassified |
| D00350 |
Itraconazole (JP18/USP); Itrizole (TN); Sporanox (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00385 |
Triamcinolone (JP18/USP/INN); Aristocort (TN); Kenacort (TN) |
(P) unclassified |
| D00407 |
Methylprednisolone (JP18/USP/INN); Medrol (TN) |
(P) Enzyme: CYP3A4 |
| D00420 |
Mitotane (JAN/USP/INN); Lysodren (TN) |
(P) unclassified |
| D00435 |
Nevirapine (JAN/USP/INN); Viramune (TN) |
(P) Enzyme: CYP3A4 |
| D00448 |
Sulfasalazine (USP/INN); Salazosulfapyridine (JP18); Azulfidine (TN) |
(P) unclassified |
| D00472 |
Prednisolone (JP18/USP/INN); Delta-cortef (TN) |
(P) unclassified |
| D00473 |
Prednisone (USP); Prednisone monohydrate; Deltasone (TN); Meticorten (TN); Rayos (TN) |
(P) unclassified |
| D00496 |
Penicillamine (JAN/USP/INN); Cuprimine (TN); Depen (TN) |
(P) unclassified |
| D00506 |
Phenobarbital (JP18/USP/INN); Luminal (TN) |
(P) unclassified |
| D00512 |
Phenytoin (JP18/USP/INN); Dilantin (TN) |
(P) CYP inhibition: CYP2C9 |
| D00550 |
Midazolam (JAN/USP/INN); Dormicum (TN); Buccolam (TN); Nayzilam (TN) |
(P) Enzyme: CYP3A4 |
| D00564 |
Warfarin sodium (USP); Coumadin (TN); Jantoven (TN) |
(P) CYP inhibition: CYP2C9 |
| D00578 |
Voriconazole (JP18/USP/INN); Vfend (TN) |
(P) unclassified |
| D00617 |
Nicardipine hydrochloride (JP18/USAN); Cardene (TN) |
(P) Enzyme: CYP3A4 |
| D00619 |
Verapamil hydrochloride (JP18/USP); Calan (TN); Covera-hs (TN); Vasolan (TN); Verelan (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00636 |
Amiodarone hydrochloride (JP18/USP); Ancaron (TN); Cordarone (TN); Nexterone (TN) |
(P) Enzyme: CYP3A4 |
| D00689 |
Beclomethasone dipropionate (USP); Beclometasone dipropionate (JP18); Beclovent (TN); Qnasl (TN); Vanceril (TN) |
(P) Enzyme: CYP3A4 |
| D00690 |
Mometasone furoate (JAN/USP); Asmanex (TN); Elocon (TN) |
(P) Enzyme: CYP3A4 |
| D00701 |
Phenobarbital sodium (JAN/USP/INN); Luminal sodium (TN) |
(P) unclassified |
| D00742 |
Etanercept (USAN/INN); Etanercept (genetical recombination) (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 1] (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 2] (JAN); Enbrel (TN) |
(P) unclassified |
| D00749 |
Leflunomide (JAN/USP/INN); Arava (TN) |
(P) Enzyme: CYP3A4 / Target: DHODH |
| D00751 |
Methylprednisolone sodium succinate (JAN/USP); A-methapred (TN); Solu-medrol (TN) |
(P) Enzyme: CYP3A4 |
| D00752 |
Mycophenolate mofetil (JAN/USP); Cellcept (TN) |
(P) unclassified |
| D00753 |
Sirolimus (JAN/USAN/INN); Rapamune (TN); Rapamycin (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D00754 |
Thalidomide (JAN/USP/INN); Thalomid (TN); Thaled (TN) |
(P) unclassified |
| D00831 |
Mefloquine hydrochloride (JP18/USP); Lariam (TN) |
(P) unclassified |
| D00892 |
Fluvastatin sodium (JAN/USP); Lescol (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2C9 |
| D00893 |
Pravastatin sodium (JP18/USP); CS-514; Pravachol (TN) |
(P) unclassified |
| D00904 |
Diclofenac sodium (JP18/USP); Solaraze (TN); Voltaren (TN) |
(P) CYP inhibition: CYP2C9 |
| D00961 |
Bicalutamide (JP18/USP/INN); Casodex (TN) |
(P) CYP inhibition: CYP3A4 |
| D00972 |
Betamethasone sodium phosphate (JP18/USP); Celestone (TN) |
(P) unclassified |
| D00973 |
Cortisone acetate (JP18/USP); Cortone acetate (TN) |
(P) unclassified |
| D00975 |
Dexamethasone sodium phosphate (JAN/USP); Dalalone (TN); Maxidex (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D00976 |
Hydrocortisone cypionate |
(P) unclassified |
| D00977 |
Hydrocortisone sodium phosphate (JP18/USP); Hydrocortone phosphate (TN) |
(P) unclassified |
| D00978 |
Hydrocortisone sodium succinate (JP18/USP); A-hydrocort (TN); Solu-cortef (TN) |
(P) unclassified |
| D00979 |
Methylprednisolone acetate (JAN/USP); Depo-medrol (TN) |
(P) Enzyme: CYP3A4 |
| D00980 |
Prednisolone acetate (JP18/USP/INN); Econopred (TN); Pred forte (TN) |
(P) unclassified |
| D00981 |
Prednisolone sodium phosphate (JP18/USP); Pediapred (TN) |
(P) unclassified |
| D00982 |
Prednisolone tebutate (JAN/USP); Hydeltra-TBA (TN) |
(P) unclassified |
| D00983 |
Triamcinolone acetonide (JP18/USP); Azmacort (TN); Kenalog (TN); Nasacort (TN) |
(P) unclassified |
| D00984 |
Triamcinolone diacetate (JAN/USP); Aristocort (TN) |
(P) unclassified |
| D00985 |
Triamcinolone hexacetonide (USP/INN); Aristospan (TN) |
(P) unclassified |
| D00986 |
Fludrocortisone acetate (JP18/USP); Florinef acetate (TN) |
(P) unclassified |
| D00991 |
Aurothioglucose (USP); Solganal (TN) |
(P) unclassified |
| D00992 |
Gold sodium thiomalate (USP); Sodium aurothiomalate (JP18); Myochrysine (TN) |
(P) unclassified |
| D01146 |
Iguratimod (JAN/INN) |
(P) unclassified |
| D01229 |
Paramethasone acetate (JAN/USAN); Haldrone (TN) |
(P) unclassified |
| D01239 |
Prednisolone sodium succinate (JP18/USP); Kohakusanin (TN) |
(P) unclassified |
| D01253 |
Clobazam (JAN/USAN/INN); Mystan (TN); Onfi (TN) |
(P) Enzyme: CYP3A4 |
| D01266 |
Difluprednate (JAN/USAN/INN); Durezol (TN) |
(P) unclassified |
| D01272 |
Clobetasol propionate (JP18/USP); Clobex (TN); Cormax (TN); Olux (TN) |
(P) unclassified |
| D01273 |
Clobetasone butyrate (JAN/USAN); Kindavate (TN) |
(P) unclassified |
| D01280 |
Warfarin potassium (JP18); Athrombin-K (TN) |
(P) CYP inhibition: CYP2C9 |
| D01308 |
Halcinonide (JAN/USP/INN); Halog (TN) |
(P) unclassified |
| D01327 |
Diflorasone diacetate (JP18/USP); Florone (TN); Psorcon (TN) |
(P) unclassified |
| D01357 |
Betamethasone valerate (JP18/USP); Beta-Val (TN); Luxiq (TN); Rinderon-V (TN) |
(P) unclassified |
| D01367 |
Fluorometholone (JP18/USP/INN); NSC 33001; Fluor-op (TN); Fml (TN); Oxylone (TN) |
(P) unclassified |
| D01370 |
Cladribine (JAN/USP/INN); Leustatin (TN); Mavenclad (TN) |
(P) unclassified |
| D01387 |
Amcinonide (JAN/USP/INN); Cyclocort (TN) |
(P) unclassified |
| D01392 |
Mizoribine (JP18/INN); Bredinin (TN) |
(P) unclassified |
| D01395 |
Actarit (JAN/INN); Orcl (TN) |
(P) unclassified |
| D01402 |
Betamethasone acetate (JAN/USP) |
(P) unclassified |
| D01434 |
Deprodone propionate (JAN); Allomidon (TN) |
(P) unclassified |
| D01442 |
Hydrocortisone succinate (JP18) |
(P) unclassified |
| D01464 |
Flumethasone pivalate (USP); Flumetasone pivalate (JAN/BAN); Locorten (TN) |
(P) unclassified |
| D01475 |
Flurbiprofen axetil (JAN); FP 83; Ropion (TN) |
(P) CYP inhibition: CYP2C9 |
| D01510 |
Dexamethasone metasulfobenzoate sodium (JAN); Dexamethazone metasulfobenzoate sodium; Dexapos; Santeson (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01566 |
Gusperimus trihydrochloride (USAN); Gusperimus hydrochloride (JAN); Spanidin (TN) |
(P) unclassified |
| D01583 |
Pirfenidone (JAN/USAN/INN); Esbriet (TN) |
(P) unclassified |
| D01615 |
Dexamethasone palmitate (JAN); Dexamethasone 21-palmitate; Limethason (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01619 |
Hydrocortisone butyrate (JP18/USP); Locoid (TN) |
(P) unclassified |
| D01632 |
Dexamethasone dipropionate (USAN); Dexamethasone propionate (JAN); Hifmeta (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01637 |
Betamethasone dipropionate (JP18/USP); Diprolene (TN); Rinderon-DP (TN); Sernivo (TN) |
(P) unclassified |
| D01689 |
Loteprednol etabonate (JAN/USAN); Lotemax (TN) |
(P) unclassified |
| D01703 |
Ciclesonide (JAN/USAN/INN); Alvesco (TN); Omnaris (TN); Zetonna (TN) |
(P) Enzyme: CYP3A4 |
| D01708 |
Fluticasone propionate (JAN/USP); Cutivate (TN); Flonase (TN); Flovent (TN) |
(P) Enzyme: CYP3A4 |
| D01764 |
Diflucortolone valerate (JP18); Afusona (TN) |
(P) unclassified |
| D01809 |
Bucillamine (JP18/INN); Bucilant (TN) |
(P) unclassified |
| D01820 |
Alclometasone dipropionate (JAN/USP); Aclovate (TN) |
(P) unclassified |
| D01825 |
Fluocinolone acetonide (JP18/USP/INN); Fluocet (TN); Retisert (TN); Synalar (TN) |
(P) unclassified |
| D01886 |
Hydrocortisone probutate (USAN); Hydrocortisone butyrate propionate (JAN); Hydrocortisone buteprate; Pandel (TN) |
(P) unclassified |
| D01948 |
Dexamethasone valerate (JAN); Dexamethasone 17-valerate; DV-17; Voalla ointment (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D01998 |
Prednisolone farnesylate (JAN); PNF 21; Farnerate (TN) |
(P) unclassified |
| D02032 |
Betamethasone butyrate propionate (JAN); Antebate (TN) |
(P) unclassified |
| D02103 |
Phenytoin sodium (USP); Phenytoin sodium for injection (JP18); Aleviatin (TN); Dilantin (TN) |
(P) CYP inhibition: CYP2C9 |
| D02115 |
Methotrexate sodium; Trexall (TN); Rasuvo (TN) |
(P) unclassified |
| D02156 |
Prednisolone hemisuccinate (USP); Prednisolone succinate (JP18) |
(P) unclassified |
| D02174 |
Dexamethasone acetate (JAN/USP); Decadronal (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02258 |
Atorvastatin calcium (USP); Atorvastatin calcium hydrate (JP18); Atorvastatin calcium trihydrate; Atorvaliq (TN); Lipitor (TN) |
(P) Enzyme: CYP3A4 |
| D02286 |
Betamethasone benzoate (USP); Uticort (TN) |
(P) unclassified |
| D02287 |
Clocortolone pivalate (USP); Cloderm (TN) |
(P) unclassified |
| D02288 |
Hydrocortisone valerate (USP); Westcort (TN) |
(P) unclassified |
| D02289 |
Medrysone (USAN); HMS (TN) |
(P) unclassified |
| D02372 |
Perospirone hydrochloride hydrate (JAN); Lullan (TN) |
(P) unclassified |
| D02484 |
Artemether and lumefantrine; Coartem (TN) |
(P) unclassified |
| D02555 |
Posaconazole (JAN/USAN/INN); Noxafil (TN) |
(P) CYP inhibition: CYP3A4 |
| D02591 |
Dexamethasone acefurate (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02592 |
Dexamethasone beloxil (USAN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D02596 |
Tocilizumab (USAN/INN); Tocilizumab (genetical recombination) (JAN); Tocilizumab (genetical recombination) [Tocilizumab biosimilar 1] (JAN); Tocilizumab-aazg; Tocilizumab-bavi; Tocilizumab-anoh; Actemra (TN); Avtozma (TN); Tofidence (TN); Tyenne (TN) |
(P) unclassified |
| D02597 |
Adalimumab (USAN/INN); Adalimumab (genetical recombination) (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 1] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 2] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 3] (JAN); Adalimumab (genetical recombination) [Adalimumab biosimilar 4] (JAN); Adalimumab-adaz; Adalimumab-adbm; Adalimumab-afzb; Adalimumab-atto; Adalimumab-bwwd; Adalimumab-fkjp; Adalimumab-aaty; Adalimumab-aacf; Adalimumab-aqvh; Adalimumab-ryvk; Humira (TN); Abrilada (TN); Amjevita (TN); Cyltezo (TN); Hadlima (TN); Hyrimoz (TN) |
(P) unclassified |
| D02598 |
Infliximab (USAN/INN); Infliximab (genetical recombination) (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 1] (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 2] (JAN); Infliximab (genetical recombination) [Infliximab biosimilar 3] (JAN); Infliximab-dyyb; Infliximab-abda; Infliximab-axxq; Remicade (TN); Inflectra (TN); Renflexis (TN); Avsola (TN); Zymfentra (TN) |
(P) unclassified |
| D02689 |
Ramelteon (JAN/USAN/INN); Rozerem (TN) |
(P) unclassified |
| D02690 |
Cholestyramine resin (USP); Colestyramine (JAN/INN); Questran (TN) |
(P) unclassified |
| D02691 |
Somatropin (USP/INN); Somatropin (genetical recombination) (JAN); Human growth hormone (JAN); Asellacrin (TN); Humatrope (TN); Nutropin (TN); Omnitrope (TN) |
(P) unclassified |
| D02714 |
Everolimus (JAN/USAN/INN); Afinitor (TN); Votubia (TN); Zortress (TN) |
(P) Enzyme: CYP3A4 |
| D02732 |
Pranlukast hydrate (JP18); Onon (TN) |
(P) Enzyme: CYP3A4 |
| D02800 |
Alefacept (USAN/INN); Amevive (TN) |
(P) unclassified |
| D02802 |
Alemtuzumab (USAN/INN); Alemtuzumab (genetical recombination) (JAN); Campath (TN); Lemtrada (TN) |
(P) unclassified |
| D02934 |
Anakinra (USAN/INN); Anakinra (genetical recombination) (JAN); Kineret (TN) |
(P) unclassified |
| D02968 |
Aprepitant (JAN/USP/INN); Aponvie (TN); Emend (TN); Cinvanti (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D02994 |
Rituximab (USAN/INN); Rituximab (genetical recombination) (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 1] (JAN); Rituximab (genetical recombination) [Rituximab biosimilar 2] (JAN); Rituximab-abbs; Rituximab-pvvr; Rituximab-arrx; Rituxan (TN); Riabni (TN); Truximab (TN) |
(P) unclassified |
| D03033 |
Azathioprine sodium (USP); Imuran (TN) |
(P) unclassified |
| D03058 |
Basiliximab (USAN/INN); Basiliximab (genetical recombination) (JAN); Simulect (TN) |
(P) unclassified |
| D03063 |
BCG vaccine (USP); Freeze-dried BCG vaccine (for percutaneous use) (JP18); BCG vaccine (TN) |
(CI) unclassified |
| D03068 |
Belimumab (USAN); Belimumab (genetical recombination) (JAN); Benlysta (TN); LymphoStat-B (TN) |
(P) unclassified |
| D03106 |
Bexarotene (JAN/USAN/INN); Targretin (TN) |
(P) unclassified |
| D03203 |
Abatacept (USAN/INN); Abatacept (genetical recombination) (JAN); Orencia (TN) |
(P) unclassified |
| D03204 |
Abetimus sodium (USAN) |
(P) unclassified |
| D03222 |
Belatacept (USAN/INN); Nulojix (TN) |
(P) unclassified |
| D03251 |
Charcoal, activated (USP); Medicinal carbon (JP18); Medicinal carbon (TN) |
(P) unclassified |
| D03256 |
Valganciclovir hydrochloride (JAN/USP); Valcyte (TN) |
(P) unclassified |
| D03301 |
Prednisolone valerate acetate (JAN); PDL; Spirazon (TN) |
(P) unclassified |
| D03325 |
Mometasone furoate hydrate (JAN); Mometasone furoate monohydrate; Nasonex (TN) |
(P) Enzyme: CYP3A4 |
| D03441 |
Certolizumab pegol (USAN/INN); Certolizumab pegol (genetical recombination) (JAN); Cimzia (TN) |
(P) unclassified |
| D03541 |
Clocortolone acetate (USAN) |
(P) unclassified |
| D03561 |
Cloprednol (USAN/INN); Cloradryn (TN) |
(P) unclassified |
| D03594 |
Cortivazol (USAN) |
(P) unclassified |
| D03639 |
Daclizumab (USAN/INN); Zenapax (TN); Zinbryta (TN) |
(P) unclassified |
| D03658 |
Dasatinib (JAN/INN) |
(P) Enzyme: CYP3A4 |
| D03669 |
Deferasirox (JAN/USAN/INN); Exjade (TN); Jadenu (TN) |
(P) CYP induction: CYP3A4 |
| D03671 |
Deflazacort (USAN/INN); Emflaza (TN) |
(P) Enzyme: CYP3A4 |
| D03684 |
Denosumab (USAN); Denosumab (genetical recombination) (JAN); Denosumab (genetical recombination) [Denosumab biosimilar 1] (JAN); Denosumab-dssb; Denosumab-bmwo; Ospomyv (TN); Prolia (TN); Ranmark (TN); Xbryk (TN); Xgeva (TN) |
(P) unclassified |
| D03696 |
Desonide (USP/INN); Desowen (TN); Verdeso (TN) |
(P) unclassified |
| D03697 |
Desoximetasone (USP/INN); Topicort (TN) |
(P) unclassified |
| D03812 |
Diflucortolone (USAN) |
(P) unclassified |
| D03813 |
Diflucortolone pivalate (USAN) |
(P) unclassified |
| D03846 |
Dimethyl fumarate (JAN/USAN); Tecfidera (TN) |
(P) unclassified |
| D03940 |
Eculizumab (USAN/INN); Eculizumab (genetical recombination) (JAN); Eculizumab-aagh; Eculizumab-aeeb; Soliris (TN); Bkemv (TN); Epysqli (TN) |
(P) unclassified |
| D03959 |
Efalizumab (USAN/INN); Raptiva (TN) |
(P) unclassified |
| D04024 |
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN); Lapatinib ditosylate monohydrate; Tykerb (TN); Tyverb (TN) |
(P) Enzyme: CYP3A4 |
| D04187 |
Fingolimod hydrochloride (JAN/USAN); Gilenya (TN) |
(P) unclassified |
| D04201 |
Flucloronide (USAN); Fluclorolone acetonide (INN) |
(P) unclassified |
| D04208 |
Flumethasone (USAN); Flumetasone (INN) |
(P) unclassified |
| D04214 |
Flunisolide acetate (USAN) |
(P) Enzyme: CYP3A4 |
| D04217 |
Fluocortin butyl (USAN) |
(P) unclassified |
| D04218 |
Fluocortolone (USAN/INN) |
(P) unclassified |
| D04219 |
Fluocortolone caproate (USAN) |
(P) unclassified |
| D04221 |
Fluorometholone acetate (USP); Fluorometholone 17-acetate; Flarex (TN) |
(P) unclassified |
| D04225 |
Fluperolone acetate (USAN); Methral (TN) |
(P) unclassified |
| D04244 |
Formocortal (USAN/INN); Deflamene (TN) |
(P) unclassified |
| D04358 |
Golimumab (USAN/INN); Golimumab (genetical recombination) (JAN); Golimumab (genetical recombination) [Golimumab biosimilar 1] (JAN); Simponi (TN) |
(P) unclassified |
| D04409 |
Halobetasol propionate (USP); Ulobetasol propionate; Ultravate (TN) |
(P) unclassified |
| D04467 |
Hydrocortisone hemisuccinate (USP) |
(P) unclassified |
| D04641 |
Istradefylline (JAN/USAN/INN); Nourianz (TN); Nouriast (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D04666 |
Lanreotide acetate (JAN/USAN); Somatuline (TN) |
(P) unclassified |
| D04687 |
Lenalidomide (JAN/USAN/INN); Revlimid (TN) |
(P) unclassified |
| D04690 |
Lenercept (USAN/INN) |
(P) unclassified |
| D04768 |
Lonafarnib (JAN/USAN/INN); Zokinvy (TN) |
(P) unclassified |
| D04866 |
Freeze-dried live attenuated measles vaccine (JP18) |
(CI) unclassified |
| D05000 |
Methylprednisolone hemisuccinate (USP); Methylprednisolone succinate (JP18) |
(P) Enzyme: CYP3A4 |
| D05001 |
Methylprednisolone sodium phosphate (USAN) |
(P) Enzyme: CYP3A4 |
| D05002 |
Methylprednisolone suleptanate (USAN/INN) |
(P) Enzyme: CYP3A4 |
| D05089 |
Freeze-dried live attenuated mumps vaccine (JP18); Freeze-dried live attenuated mumps vaccine (TN) |
(CI) unclassified |
| D05092 |
Muromonab-CD3 (JAN/USAN/INN); Orthoclone okt3 (TN) |
(P) unclassified |
| D05094 |
Mycophenolate mofetil hydrochloride (USAN); Cellcept (TN) |
(P) unclassified |
| D05095 |
Mycophenolate sodium (USP); Myfortic (TN) |
(P) unclassified |
| D05096 |
Mycophenolic acid (USAN/INN); Mycophenolic acid (TN) |
(P) unclassified |
| D05146 |
Nerelimomab (USAN/INN) |
(P) unclassified |
| D05182 |
Influenza HA vaccine (JP18) |
(P) unclassified |
| D05218 |
Ocrelizumab (USAN); Ocrelizumab (genetical recombination) (JAN); Ocrevus (TN) |
(P) unclassified |
| D05248 |
Freeze-dried inactivated tissue culture ravies vaccine (JP18) |
(P) unclassified |
| D05263 |
Onercept (USAN/INN) |
(P) unclassified |
| D05393 |
Pegsunercept (USAN) |
(P) unclassified |
| D05601 |
Prednicarbate (USP/INN); Dermatop (TN) |
(P) unclassified |
| D05719 |
Resocortol butyrate (USAN) |
(P) unclassified |
| D05729 |
Rimexolone (USP/INN); Vexol (TN) |
(P) unclassified |
| D05775 |
Rufinamide (JAN/USP/INN); Banzel (TN) |
(P) unclassified |
| D05928 |
Stiripentol (JAN/USAN/INN); Diacomit (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D06171 |
Tixocortol pivalate (USAN) |
(P) unclassified |
| D06216 |
Triamcinolone acetonide sodium phosphate (USAN) |
(P) unclassified |
| D06315 |
Fluticasone furoate (JAN/USAN/INN); Veramyst (TN) |
(P) Enzyme: CYP3A4 |
| D06347 |
Yellow fever vaccine (USP); YF-Vax (TN) |
(CI) unclassified |
| D06413 |
Nilotinib hydrochloride hydrate (JAN); Nilotinib monohydrochloride monohydrate; Tasigna (TN) |
(P) Enzyme: CYP3A4 |
| D06414 |
Dasatinib (USAN); Dasatinib hydrate (JAN); Sprycel (TN) |
(P) Enzyme: CYP3A4 |
| D06466 |
Freeze-dried BCG for intravesical use; Immunobladder (TN); Tice BCG (TN) |
(CI) unclassified |
| D06475 |
Adsorbed hepatitis B vaccine (JP18); Bimmugen (TN) |
(P) unclassified |
| D06511 |
Freeze-dried smallpox vaccine prepared in cell culture (JP18) |
(CI) unclassified |
| D06512 |
Freeze-dried live attenuated rubella vaccine (JP18) |
(CI) unclassified |
| D06597 |
Fosaprepitant dimeglumine (USAN); Fosaprepitant meglumine (JAN); Proemend (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 / CYP induction: CYP3A4 |
| D06635 |
Rilonacept (USAN/INN); Arcalyst (TN) |
(P) unclassified |
| D06673 |
Meprednisone (USP/INN) |
(P) unclassified |
| D06876 |
Hydrocortisone aceponate (INN); Efficort (TN) |
(P) unclassified |
| D06886 |
Natalizumab (USAN/INN); Natalizumab (genetical recombination) (JAN); Tysabri (TN) |
(P) unclassified |
| D07073 |
Dexamethasone cipecilate (JAN/INN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07116 |
Alclometasone (INN) |
(P) unclassified |
| D07201 |
Fluprednidene (INN) |
(P) unclassified |
| D07202 |
Halometasone (INN) |
(P) unclassified |
| D07203 |
Methylprednisolone aceponate (INN); Advantan (TN) |
(P) Enzyme: CYP3A4 |
| D07230 |
Prednylidene (INN) |
(P) unclassified |
| D07436 |
Afelimomab (INN) |
(P) unclassified |
| D07464 |
Paramethasone (INN); Dillar (TN) |
(P) unclassified |
| D07478 |
Aurotioprol; Allochrysine (TN) |
(P) unclassified |
| D07495 |
Beclometasone (INN); Beclometason (TN) |
(P) unclassified |
| D07583 |
Phenytoin and phenobarbital; Aleviatin with phenobarbital (TN) |
(P) CYP inhibition: CYP2C9 |
| D07595 |
Fosphenytoin sodium hydrate (JAN); Fostoin (TN) |
(P) CYP inhibition: CYP2C9 / CYP induction: CYP3A4 |
| D07715 |
Clobetasol (INN); Clobecort Amex (TN) |
(P) unclassified |
| D07717 |
Clobetasone (INN) |
(P) unclassified |
| D07719 |
Clocortolone (INN) |
(P) unclassified |
| D07749 |
Cortisone (INN); Cortisone (TN) |
(P) unclassified |
| D07796 |
Dexamethasone 21-acetate; Dexamethasone acetate anhydrous; Decaject-L.A. (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07797 |
Dexamethasone isonicotinate; Dexamethasone 21-isonicotinate; Voren [veterinary] (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07798 |
Dexamethasone sodium hemisulfate; Dexamethasone 21-sodium sulfate; Colircusi Dexametasona (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07799 |
Dexamethasone 21-tebutate; Dexamethasone tertiary butyl acetate; Dexamedium [veterinary] (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07800 |
Dexamethasone 21-valerate; Voalla (TN); Zalucs (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07801 |
Dexamethasone phenylpropionate; Dexafort [veterinary] (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07802 |
Dexamethasone phosphate; Decadron-phosphate (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D07827 |
Diflorasone (INN); Murode (TN) |
(P) unclassified |
| D07967 |
Fludrocortisone (INN); Astonin-H (TN) |
(P) unclassified |
| D07972 |
Fluocortin (INN) |
(P) unclassified |
| D07973 |
Fluocortolone 21-pivalate; Fluocortolone pivalate; Ultradil (TN) |
(P) unclassified |
| D07980 |
Fluprednidene acetate; Fluprednidene 21-acetate; Decoderm (TN) |
(P) unclassified |
| D07981 |
Fluticasone (INN); Fluticaps (TN) |
(P) Enzyme: CYP3A4 |
| D08032 |
Gusperimus (INN); 15-Deoxyspergualin |
(P) unclassified |
| D08083 |
Vedolizumab (USAN); Vedolizumab (genetical recombination) (JAN); Entyvio (TN) |
(P) unclassified |
| D08147 |
Loteprednol (INN) |
(P) unclassified |
| D08227 |
Mometasone (INN) |
(P) Enzyme: CYP3A4 |
| D08330 |
Penicillamine hydrochloride; Pemine (TN) |
(P) unclassified |
| D08412 |
Prednisolone pivalate; Prednisolone 21-pivalate; Ultracortenol (TN) |
(P) unclassified |
| D08413 |
Prednisolone sodium metazoate (USAN); Prednisolone metasulfobenzoate sodium; Prednisolone 21-(sodium 3-sulfobenzoate); Predenema (TN) |
(P) unclassified |
| D08414 |
Prednisolone 21-(sodium tetrahydrophthalate); Prednisolone sodium tetrahydrophthalate; Fenicort (TN) |
(P) unclassified |
| D08415 |
Prednisolone steaglate (BAN); Prednisolone 21-steaglate; Sintisone (TN) |
(P) unclassified |
| D08416 |
Prednisone acetate; Prednisone 21-acetate |
(P) unclassified |
| D08476 |
Resocortol (INN) |
(P) unclassified |
| D08479 |
Rifampicin sodium; Rifadine (TN) |
(P) CYP induction: CYP3A4 |
| D08488 |
Amlodipine besilate and atorvastatin calcium; Caduet (TN) |
(P) Enzyme: CYP3A4 |
| D08521 |
Sodium aurothiosulfate (INN); Gold sodium thiosulfate, dihydrate; Crytioro (TN) |
(P) unclassified |
| D08556 |
Tacrolimus (INN); Prograf (TN) |
(P) Enzyme: CYP3A4 |
| D08610 |
Tixocortol (INN) |
(P) unclassified |
| D08660 |
Ulobetasol (INN); Halobetasol |
(P) unclassified |
| D08682 |
Warfarin (INN); Warfarine; Choice (TN) |
(P) CYP inhibition: CYP2C9 |
| D08776 |
Pneumococcal vaccine polyvalent; Pneumococcus vaccine; Pneumovax 23 (TN) |
(P) unclassified |
| D08777 |
Freeze-dried live attenuated varicella vaccine |
(CI) unclassified |
| D08804 |
Freeze-dried live attenuated measles-rubella combined vaccine; Mearubik (TN) |
(CI) unclassified |
| D08808 |
Anti-human thymocyte immunoglobulin, equine (JAN); Atgam (TN); Lymphoglobuline (TN) |
(P) unclassified |
| D08860 |
Apremilast (JAN/USAN); Otezla (TN) |
(P) unclassified |
| D08976 |
Pomalidomide (JAN/USAN/INN); Pomalyst (TN) |
(P) Enzyme: CYP3A4 |
| D09033 |
Voclosporin (JAN/USAN/INN); Lupkynis (TN) |
(P) Enzyme: CYP3A4 |
| D09190 |
Anti-human thymocyte immunoglobulin, rabbit (JAN); Thymoglobuline (TN) |
(P) unclassified |
| D09214 |
Ustekinumab (USAN/INN); Ustekinumab (genetical recombination) (JAN); Ustekinumab (genetical recombination) [Ustekinumab biosimilar 1] (JAN); Ustekinumab (genetical recombination) [Ustekinumab biosimilar 2] (JAN); Ustekinumab (genetical recombination) [Ustekinumab biosimilar 3] (JAN); Ustekinumab-aauz; Ustekinumab-auub; Ustekinumab-ttwe; Ustekinumab-aekn; Ustekinumab-srlf; Stelara (TN); Otulfi (TN); Pyzchiva (TN); Wezlana (TN) |
(P) unclassified |
| D09314 |
Ofatumumab (USAN/INN); Ofatumumab (genetical recombination) (JAN); Arzerra (TN); Kesimpta (TN) |
(P) unclassified |
| D09315 |
Canakinumab (USAN/INN); Canakinumab (genetical recombination) (JAN); Ilaris (TN) |
(P) unclassified |
| D09588 |
Briakinumab (USAN/INN) |
(P) unclassified |
| D09638 |
Lomitapide mesylate (USAN); Lomitapide mesilate (JAN); Juxtapid (TN); Lojuxta (TN) |
(P) Enzyme: CYP3A4 |
| D09669 |
Siltuximab (USAN/INN); Sylvant (TN) |
(P) unclassified |
| D09680 |
Teprotumumab (USAN/INN); Teprotumumab (genetical recombination) (JAN); Teprotumumab-trbw; Tepezza (TN) |
(P) unclassified |
| D09731 |
Crizotinib (JAN/USAN/INN); Xalkori (TN) |
(P) Enzyme: CYP3A4 |
| D09783 |
Tofacitinib citrate (JAN/USAN); Tasocitinib citrate; Xeljanz (TN) |
(P) Enzyme: CYP3A4 |
| D09796 |
Hydrocortisone caproate (JAN) |
(P) unclassified |
| D09799 |
Carotegrast methyl (JAN); Carogra (TN) |
(P) CYP inhibition: CYP3A4 |
| D09813 |
Lenalidomide hydrate (JAN); Revlimid (TN) |
(P) unclassified |
| D09944 |
Ozoralizumab (USAN); Ozoralizumab (genetical recombination) (JAN); Nanozora (TN) |
(P) unclassified |
| D09959 |
Ruxolitinib (USAN/INN) |
(P) Enzyme: CYP3A4 |
| D09960 |
Ruxolitinib phosphate (JAN/USAN); Jakafi (TN); Jakavi (TN); Opzelura (TN) |
(P) Enzyme: CYP3A4 |
| D09967 |
Secukinumab (USAN/INN); Secukinumab (genetical recombination) (JAN); Cosentyx (TN) |
(P) unclassified |
| D09970 |
Tofacitinib (USAN); Tasocitinib |
(P) Enzyme: CYP3A4 |
| D09996 |
Vemurafenib (JAN/USAN/INN); Zelboraf (TN) |
(P) CYP induction: CYP3A4 |
| D10001 |
Fingolimod (INN); Gilenya (TN) |
(P) unclassified |
| D10003 |
Hemin (JAN); Normosang (TN); Panhematin (TN) |
(P) CYP induction: CYP3A4 |
| D10061 |
Brodalumab (USAN); Brodalumab (genetical recombination) (JAN); Siliq (TN) |
(P) unclassified |
| D10071 |
Ixekizumab (USAN); Ixekizumab (genetical recombination) (JAN); Taltz (TN) |
(P) unclassified |
| D10080 |
Sirukumab (USAN); Sirukumab (genetical recombination) (JAN) |
(P) unclassified |
| D10104 |
Dabrafenib mesylate (USAN); Dabrafenib mesilate (JAN); Tafinlar (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D10141 |
Oclacitinib (USAN) |
(P) unclassified |
| D10142 |
Oclacitinib maleate (USAN) |
(P) unclassified |
| D10161 |
Sarilumab (USAN); Sarilumab (genetical receombination) (JAN); Kevzara (TN) |
(P) unclassified |
| D10172 |
Teriflunomide (USAN); Aubagio (TN) |
(P) Target: DHODH |
| D10187 |
Pateclizumab (USAN) |
(P) unclassified |
| D10192 |
Recombinant adsorbed quadrivalent human papillomavirus virus-like particle vaccine (yeast origin); Gardasil (TN); Silgard (TN) |
(P) unclassified |
| D10212 |
Recombinant adsorbed bivalent human papillomavirus-like particle vaccine (derived from Trichoplusia ni cells); Cervarix (TN) |
(P) unclassified |
| D10218 |
Enzalutamide (JAN/USAN); Xtandi (TN) |
(P) unclassified |
| D10308 |
Baricitinib (JAN/USAN/INN); Olumiant (TN) |
(P) unclassified |
| D10315 |
Momelotinib (USAN/INN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2C9 |
| D10320 |
Placulumab (USAN/INN) |
(P) unclassified |
| D10358 |
Momelotinib dihydrochloride (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2C9 |
| D10365 |
Gandotinib (USAN/INN) |
(P) unclassified |
| D10372 |
Palbociclib (JAN/USAN); Ibrance (TN) |
(P) unclassified |
| D10385 |
Ezetimibe and atorvastatin; Atozet (TN); Liptruzet (TN) |
(P) Enzyme: CYP3A4 |
| D10400 |
Tildrakizumab (USAN); Tildrakizumab (genetical recombination) (JAN); Tildrakizumab-asmn; Ilumya (TN) |
(P) unclassified |
| D10438 |
Guselkumab (USAN/INN); Guselkumab (genetical recombination) (JAN); Tremfya (TN) |
(P) unclassified |
| D10466 |
Vonoprazan fumarate (JAN/USAN); Takecab (TN); Voquezna (TN) |
(P) Enzyme: CYP3A4 |
| D10528 |
Aldosterone (INN) |
(P) unclassified |
| D10551 |
Ceritinib (JAN/USAN/INN); Zykadia (TN) |
(P) unclassified |
| D10564 |
Amenamevir (JAN/INN); Amenalief (TN) |
(P) unclassified |
| D10566 |
Pasireotide pamoate (JAN); Signifor lar (TN) |
(P) unclassified |
| D10585 |
Decernotinib (USAN/INN); Adelatinib |
(P) unclassified |
| D10630 |
Fedratinib (USAN/INN) |
(P) Enzyme: CYP3A4 |
| D10643 |
Isavuconazonium sulfate (JAN/USAN); Cresemba (TN) |
(P) unclassified |
| D10653 |
Peficitinib (USAN/INN) |
(P) unclassified |
| D10721 |
Peficitinib hydrobromide (JAN/USAN); Smyraf (TN) |
(P) unclassified |
| D10728 |
Solcitinib (USAN/INN) |
(P) unclassified |
| D10746 |
Esflurbiprofen and mentha oil; Loqoa (TN) |
(P) CYP inhibition: CYP2C9 |
| D10762 |
Fosravuconazole L-lysine ethanolate (JAN) |
(P) unclassified |
| D10774 |
Vonoprazan, amoxicillin and metronidazole; Vonopion (TN) |
(P) Enzyme: CYP3A4 |
| D10775 |
Vonoprazan, amoxicillin and clarithromycin; Vonosap (TN); Voquenza (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP3A4 |
| D10801 |
Letermovir (JAN/USAN/INN); Prevymis (TN) |
(P) unclassified |
| D10871 |
Filgotinib (USAN/INN) |
(P) unclassified |
| D10872 |
Filgotinib hydrochloride (USAN) |
(P) unclassified |
| D10889 |
Momelotinib hydrochloride hydrate (JAN); Momelotinib dihydrochloride monohydrate; Ojjaara (TN); Omjjara (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2C9 |
| D10926 |
Entrectinib (JAN/USAN/INN); Rozlytrek (TN) |
(P) Enzyme: CYP3A4 |
| D10927 |
Erdafitinib (JAN/USAN/INN); Balversa (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2C9 |
| D10930 |
Etrasimod (USAN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2C9 |
| D10931 |
Etrasimod arginine (USAN); Etrasimod L-arginine (JAN); Velsipity (TN) |
(P) Enzyme: CYP3A4 / CYP inhibition: CYP2C9 |
| D10944 |
Itacitinib (USAN/INN) |
(P) unclassified |
| D10945 |
Itacitinib adipate (JAN/USAN) |
(P) unclassified |
| D10967 |
Ozanimod hydrochloride (JAN/USAN); Zeposia (TN) |
(P) unclassified |
| D10968 |
Ozanimod (USAN/INN) |
(P) unclassified |
| D10990 |
Somatrogon (USAN/INN); Somatrogon (genetical recombination) (JAN); Somatrogon-ghla; Ngenla (TN) |
(P) unclassified |
| D10994 |
Upadacitinib (USAN/INN) |
(P) Enzyme: CYP3A4 |
| D10995 |
Upadacitinib tartrate (USAN) |
(P) Enzyme: CYP3A4 |
| D11000 |
Vamorolone (USAN/INN); Agamree (TN) |
(P) Enzyme: CYP3A4 |
| D11012 |
Lorlatinib (JAN/USAN/INN); Lorbrena (TN) |
(P) unclassified |
| D11040 |
Apalutamide (JAN/INN); Erleada (TN) |
(P) Enzyme: CYP3A4 / CYP induction: CYP3A4 |
| D11046 |
Delgocitinib (JAN/USAN/INN); Corectim (TN); Anzupgo (TN) |
(P) unclassified |
| D11048 |
Upadacitinib hydrate (JAN); Upadacitinib hemihydrate; Rinvoq (TN) |
(P) Enzyme: CYP3A4 |
| D11052 |
Risankizumab (USAN/INN); Risankizumab (genetical recombination) (JAN); Risankizumab-rzaa; Skyrizi (TN) |
(P) unclassified |
| D11053 |
Encorafenib (JAN/USAN/INN); Braftovi (TN) |
(P) Enzyme: CYP3A4 |
| D11054 |
Ravulizumab (USAN/INN); Ravulizumab (genetical recombination) (JAN); Ultomiris (TN) |
(P) unclassified |
| D11072 |
Siponimod fumarate (USAN); Siponimod fumaric acid (JAN); Mayzent (TN) |
(P) CYP inhibition: CYP2C9 |
| D11079 |
Satralizumab (USAN/INN); Satralizumab (genetical recombination) (JAN); satralizumab-mwge; Enspryng (TN) |
(P) unclassified |
| D11082 |
Anifrolumab (USAN); Anifrolumab (genetical recombination) (JAN); Anifrolumab-fnia; Saphnelo (TN) |
(P) unclassified |
| D11090 |
Ivosidenib (JAN/USAN/INN); Tibsovo (TN) |
(P) unclassified |
| D11093 |
Avacopan (JAN/USAN/INN); Tavneos (TN) |
(P) Enzyme: CYP3A4 |
| D11106 |
Filgotinib maleate (JAN/USAN); Jyseleca (TN) |
(P) unclassified |
| D11120 |
Emapalumab (USAN/INN); Emapalumab (genetical recombination) (JAN); Emapalumab-lzsg; Gamifant (TN) |
(P) unclassified |
| D11123 |
Mirikizumab (USAN/INN); Mirikizumab (genetical recombination) (JAN); Mirikizumab-mrkz; Omvoh (TN) |
(P) unclassified |
| D11138 |
Larotrectinib sulfate (JAN/USAN); Vitrakvi (TN) |
(P) unclassified |
| D11154 |
Diroximel fumarate (JAN/USAN/INN); Vumerity (TN) |
(P) unclassified |
| D11194 |
Somapacitan (USAN/INN); Somapacitan (genetical recombination) (JAN); Somapacitan-beco; Sogroya (TN) |
(P) unclassified |
| D11215 |
Ponesimod (USAN/INN); Ponvory (TN) |
(P) unclassified |
| D11243 |
Ublituximab (USAN/INN); Briumvi (TN) |
(P) unclassified |
| D11296 |
Fedratinib hydrochloride (USAN); Fedratinib hydrochloride hydrate (JAN); Fedratinib dihydrochloride monohydrate; Inrebic (TN) |
(P) Enzyme: CYP3A4 |
| D11370 |
Fosnetupitant chloride hydrochloride (JAN/USAN); Arokaris (TN) |
(P) unclassified |
| D11371 |
Capivasertib (JAN/USAN); Truqap (TN) |
(P) Enzyme: CYP3A4 |
| D11397 |
Darvadstrocel (INN); Alofisel (TN) |
(P) unclassified |
| D11400 |
Abrocitinib (JAN/USAN); Cibinqo (TN) |
(P) CYP inhibition: CYP2C9 |
| D11422 |
Zanubrutinib (JAN/USAN/INN); Brukinsa (TN) |
(P) unclassified |
| D11454 |
Repotrectinib (JAN/USAN); Augtyro (TN) |
(P) Enzyme: CYP3A4 |
| D11460 |
Siponimod (USAN/INN) |
(P) CYP inhibition: CYP2C9 |
| D11470 |
Imlifidase (USAN/INN); Idefirix (TN) |
(P) unclassified |
| D11477 |
Pozelimab (USAN); Pozelimab-bbfg; Veopoz (TN) |
(P) unclassified |
| D11485 |
Tazemetostat hydrobromide (JAN/USAN); Tazverik (TN) |
(P) unclassified |
| D11530 |
Sutimlimab (USAN/INN); Sutimlimab (genetical recombination) (JAN); Sutimlimab-jome; Enjaymo (TN) |
(P) unclassified |
| D11537 |
Brepocitinib (USAN) |
(P) unclassified |
| D11538 |
Brepocitinib tosylate (USAN) |
(P) unclassified |
| D11550 |
Bimekizumab (USAN/INN); Bimekizumab (genetical recombination) (JAN); Bimzelx (TN) |
(P) unclassified |
| D11557 |
Tecovirimat hydrate (JAN); Tecovirimat monohydrate; Tpoxx (TN); Tepoxx (TN) |
(P) unclassified |
| D11572 |
Beclomethasone dipropionate monohydrate; Beconase aq (TN) |
(P) Enzyme: CYP3A4 |
| D11599 |
Zotiraciclib (USAN) |
(P) unclassified |
| D11600 |
Zotiraciclib citrate (USAN) |
(P) unclassified |
| D11613 |
Pegcetacoplan (JAN/USAN/INN); Empaveli (TN) |
(P) unclassified |
| D11641 |
Danicopan (JAN/USAN/INN); Voydeya (TN) |
(P) unclassified |
| D11674 |
Berotralstat hydrochloride (JAN/USAN); Orladeyo (TN) |
(P) CYP inhibition: CYP3A4 |
| D11676 |
Gusacitinib (USAN/INN) |
(P) unclassified |
| D11677 |
Gusacitinib hydrochloride (USAN) |
(P) unclassified |
| D11696 |
Crovalimab (USAN/INN); Crovalimab (genetical recombination) (JAN); Crovalimab-akkz; Piasky (TN) |
(P) unclassified |
| D11703 |
Opinercept (INN) |
(P) unclassified |
| D11713 |
Selpercatinib (JAN/USAN/INN); Retevmo (TN) |
(P) Enzyme: CYP3A4 |
| D11757 |
Inebilizumab (USAN/INN); Inebilizumab (genetical recombination) (JAN); Inebilizumab-cdon; Uplizna (TN) |
(P) unclassified |
| D11768 |
Pacritinib (USAN/INN); Vonjo (TN) |
(P) Enzyme: CYP3A4 |
| D11804 |
Aspirin and vonoprazan; Cabpirin (TN) |
(P) unclassified |
| D11815 |
Belumosudil (USAN) |
(P) unclassified |
| D11816 |
Belumosudil mesylate (USAN); Belumosudil mesilate (JAN); Rezurock (TN) |
(P) unclassified |
| D11817 |
Deucravacitinib (JAN/USAN); Sotyktu (TN) |
(P) unclassified |
| D11838 |
Vilobelimab (USAN); Gohibic (TN) |
(P) unclassified |
| D11863 |
Human papillomavirus 9-valent vaccine, recombinant; Recombinant adsorbed 9-valent human papillomavirus virus-like particle vaccine (yeast origin); Gardasil 9 (TN); Silgard 9 (TN) |
(P) unclassified |
| D11866 |
Deuruxolitinib (USAN) |
(P) CYP inhibition: CYP2C9 |
| D11867 |
Deuruxolitinib phosphate (USAN); Leqselvi (TN) |
(P) CYP inhibition: CYP2C9 |
| D11876 |
Efgartigimod alfa (USAN/INN); Efgartigimod alfa (genetical recombination) (JAN); Efgartigimod alfa-fcab; Vyvgart (TN) |
(P) unclassified |
| D11887 |
Daridorexant hydrochloride (JAN/USAN); Quviviq (TN) |
(P) unclassified |
| D11920 |
Pimitespib (JAN); Jeselhy (TN) |
(P) unclassified |
| D11954 |
Belzutifan (JAN/USAN/INN); Welireg (TN) |
(P) unclassified |
| D11970 |
Ritlecitinib tosylate (USAN); Ritlecitinib tosilate (JAN); Litfulo (TN) |
(P) unclassified |
| D12050 |
Pirtobrutinib (JAN/USAN); Jaypirca (TN) |
(P) Enzyme: CYP3A4 |
| D12055 |
Sotorasib (JAN/USAN); Lumakras (TN) |
(P) unclassified |
| D12066 |
Spesolimab (USAN/INN); Spesolimab (genetical recombination) (JAN); Spesolimab-sbzo; Spevigo (TN) |
(P) unclassified |
| D12118 |
Nezulcitinib (USAN) |
(P) unclassified |
| D12182 |
Rozanolixizumab (USAN/INN); Rozanolixizumab (genetical recombination) (JAN); rozanolixizumab-noli; Rystiggo (TN) |
(P) unclassified |
| D12211 |
Ivarmacitinib (USAN) |
(P) unclassified |
| D12212 |
Ivarmacitinib sulfate (USAN) |
(P) unclassified |
| D12245 |
Lazertinib mesylate (USAN); Lazertinib mesilate hydrate (JAN); Lazcluze (TN) |
(P) Enzyme: CYP3A4 |
| D12251 |
Iptacopan (USAN/INN) |
(P) unclassified |
| D12252 |
Iptacopan hydrochloride (USAN); Iptacopan hydrochloride hydrate (JAN); Iptacopan hydrochloride monohydrate; Fabhalta (TN) |
(P) unclassified |
| D12285 |
Remibrutinib (JAN/USAN/INN) |
(P) unclassified |
| D12353 |
Ensitrelvir fumarate (USAN); Ensitrelvir fumaric acid (JAN); Xocova (TN) |
(P) unclassified |
| D12356 |
Zilucoplan sodium (JAN); Zilbrysq (TN) |
(P) unclassified |
| D12357 |
Zilucoplan (USAN/INN) |
(P) unclassified |
| D12487 |
Olokizumab (INN) |
(P) unclassified |
| D12502 |
Golidocitinib (USAN/INN) |
(P) unclassified |
| D12575 |
Povorcitinib (USAN/INN) |
(P) unclassified |
| D12576 |
Povorcitinib phosphate (USAN) |
(P) unclassified |
| D12586 |
Mifepristone and misoprostol; Mefeego (TN) |
(P) unclassified |
| D12684 |
Efgartigimod alfa and hyaluronidase; Efgartigimod alfa (genetical recombination) and vorhyaluronidase alfa (genetical recombination); Efgartigimod alfa and hyaluronidase-qvfc; Vyvgard hytrulo (TN); Vyvdura (TN) |
(P) unclassified |
| D12747 |
Divozilimab (INN) |
(P) unclassified |
| D12748 |
Levilimab (INN) |
(P) unclassified |
| D12786 |
Lepzacitinib (USAN) |
(P) unclassified |
| D12874 |
Influenza vaccine live, intranasal; Live attenuated influenza virus vaccine, intranasal; Influenza vaccine (live attenuated, nasal); Flumist (TN); Fluenz (TN) |
(CI) unclassified |
| D12993 |
Frevecitinib (USAN/INN) |
(P) unclassified |
| D13040 |
Londamocitinib (USAN/INN) |
(P) unclassified |
| D13041 |
Londamocitinib xinafoate (USAN) |
(P) unclassified |
